Showing 1 - 5 results of 5 for search 'Claus Garbe', query time: 0.02s
Refine Results
-
1
Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy? by Konstantin Nikolaou, Andrea Forschner, Benjamin Weide, Claus Garbe, Christina Pfannenberg, Ahmed E Othman, Johannes Schwenck, Christian la Fougère, Ferdinand Seith, Brigitte Gückel, Martin Schwartz, Matthias Fenchel, Nina Schwenzer
Published 2020-10-01Get full text
Article -
2
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients by Carola Berking, Jessica C Hassel, Lisa Zimmer, Ralf Gutzmer, Teresa Amaral, Thomas Eigentler, Claus Garbe, Julia Tietze, Thilo Gambichler, Patrick Terheyden, Felix Kiecker, Sarah Schaefer, Henner Stege, Katharina Kaehler, Sebastian Haferkamp, Jochen Uttikal, David Rafei-Shamsabadi, Lydia Reinhardt, Friedegund Meier, Ante Karoglan, Christian Posch, Claudia Pfoehler, Kai Thoms, Dirk Debus, Rudolf Herbst, Steffen Emmert, Carmen Loquai, Frank Meiss, Thomas Tueting, Vanessa Heinrich
Published 2020-05-01Get full text
Article -
3
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients by Dirk Schadendorf, Lucie Heinzerling, Jessica C Hassel, Lisa Zimmer, Ralf Gutzmer, Elisabeth Livingstone, Selma Ugurel, Ulrike Keim, Claus Garbe, Valerie Glutsch, Peter Mohr, Thilo Gambichler, Patrick Terheyden, Katharina Kaehler, Sebastian Haferkamp, David Rafei-Shamsabadi, Lydia Reinhardt, Claudia Pfoehler, Carmen Loquai, Michael Weichenthal, Jürgen Christian Becker, Ulrike Leiter, Judith Sirokay, Nora Schlecht, Albert Rübben, Kerstin Schatton, Cindy Franklin, Lena Bischof, Andreas Meiwes
Published 2020-10-01Get full text
Article -
4
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma by Dirk Schadendorf, Ralf Gutzmer, Caroline Robert, Celeste Lebbe, Gabriella Liszkay, Inge Marie Svane, Omid Hamid, Paolo Antonio Ascierto, Catriona McNeil, Claus Garbe, Michele Maio, Vanna Chiarion-Sileni, Luc Thomas, Andrzej Mackiewicz, Carmen Loquai, Ana Arance, Piotr Rutkowski, Laurent Mortier, Lars Bastholt, Brigitte Dreno, Marta Nyakas, Jean-Jacques Grob, Michael Smylie, Christoph Hoeller, Virginia Ferraresi, Florent Grange, Joanna Pikiel, Fareeda Hosein, Burcin Simsek, Michele Del Vecchio
Published 2020-05-01Get full text
Article -
5
German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023 by Ulrike Leiter, Markus V. Heppt, Theresa Steeb, Mareike Alter, Teresa Amaral, Andrea Bauer, Falk G. Bechara, Jürgen C. Becker, Eckhard W. Breitbart, Helmut Breuninger, Thomas Diepgen, Thomas Dirschka, Thomas Eigentler, A.K. Stephan El Gammal, Moritz Felcht, Michael J. Flaig, Markus Follmann, Klaus Fritz, Stephan Grabbe, Rüdiger Greinert, Ralf Gutzmer, Axel Hauschild, Uwe Hillen, Stephan Ihrler, Swen Malte John, Lukas Kofler, Oliver Koelbl, Albrecht Krause-Bergmann, Klaus Kraywinkel, Steffen Krohn, Thomas Langer, Carmen Loquai, Christoph R. Löser, Peter Mohr, Dorothée Nashan, Monika Nothacker, Christina Pfannenberg, Carmen Salavastru, Lutz Schmitz, Eggert Stockfleth, Rolf-Markus Szeimies, Claas Ulrich, Susanne Voelter-Mahlknecht, Dirk Vordermark, Michael Weichenthal, Julia Welzel, Kai Wermker, Susanne Wiegand, Claus Garbe, Carola Berking
Published 2023-01-01Get full text
Article